Search results for " Therapeutic"

showing 10 items of 340 documents

La supervisione: strumento di formazione continua per operatori di Comunità Terapeutiche Assistite.

2012

lavoro nelle organizzazioni sociali si presenta oggi complesso e oltremodo denso di criticità. La trasformazione dei quadri di riferimento normativi, la complessità socio-politica e le difficoltà legate agli specifici interventi incidono profondamente sui gruppi di lavoro che o-perano nel sociale, incrementando la già diffusa necessità di essere supportati. Il seguente lavo-ro, a tal fine, terrà fortemente in considerazione la ricchezza e la pluralità dei bisogni che gli operatori del sociale (cooperative, comunità, ecc.) esprimono, rimandando ad un’idea di “cura del loro sviluppo e della loro funzione” complessa e variegata (Basaglia, 1968). È in questa pro-spettiva che lo strumento della …

Supervision operators therapeutic communities assistedsupervisione operatori comunità terapeutiche assistite
researchProduct

CXCR7 Reactivates ERK Signaling to Promote Resistance to EGFR Kinase Inhibitors in NSCLC

2019

Abstract Although EGFR mutant–selective tyrosine kinase inhibitors (TKI) are clinically effective, acquired resistance can occur by reactivating ERK. We show using in vitro models of acquired EGFR TKI resistance with a mesenchymal phenotype that CXCR7, an atypical G protein-coupled receptor, activates the MAPK–ERK pathway via β-arrestin. Depletion of CXCR7 inhibited the MAPK pathway, significantly attenuated EGFR TKI resistance, and resulted in mesenchymal-to-epithelial transition. CXCR7 overexpression was essential in reactivation of ERK1/2 for the generation of EGFR TKI–resistant persister cells. Many patients with non–small cell lung cancer (NSCLC) harboring an EGFR kinase domain mutatio…

0301 basic medicineMAPK/ERK pathwayCancer ResearchLung NeoplasmsDrug ResistanceDrug resistanceTransgenicMiceChemokine receptor0302 clinical medicineNeoplasmsCarcinoma Non-Small-Cell LungReceptorsMedicineNon-Small-Cell LungCXCRReceptorLungbeta-ArrestinsCancerEGFR inhibitorsTumorKinaseLung CancerErbB ReceptorsOncology5.1 Pharmaceuticals030220 oncology & carcinogenesisDevelopment of treatments and therapeutic interventionsTyrosine kinaseEpithelial-Mesenchymal TransitionMAP Kinase Signaling SystemOncology and CarcinogenesisMice TransgenicArticleCell LineExperimental03 medical and health sciencesClinical ResearchCell Line TumorAnimalsHumansOncology & CarcinogenesisProtein Kinase InhibitorsReceptors CXCRbusiness.industryCarcinomaNeoplasms Experimentalrespiratory tract diseases030104 developmental biologyProtein kinase domainDrug Resistance NeoplasmMutationCancer researchNeoplasmbusinessCancer Research
researchProduct

CRISPR-Cas9 screen reveals a MYCN-amplified neuroblastoma dependency on EZH2.

2018

Pharmacologically difficult targets, such as MYC transcription factors, represent a major challenge in cancer therapy. For the childhood cancer neuroblastoma, amplification of the oncogene MYCN is associated with high-risk disease and poor prognosis. Here, we deployed genome-scale CRISPR-Cas9 screening of MYCN-amplified neuroblastoma and found a preferential dependency on genes encoding the polycomb repressive complex 2 (PRC2) components EZH2, EED, and SUZ12. Genetic and pharmacological suppression of EZH2 inhibited neuroblastoma growth in vitro and in vivo. Moreover, compared with neuroblastomas without MYCN amplification, MYCN-amplified neuroblastomas expressed higher levels of EZH2. ChIP…

0301 basic medicineCellular differentiationMedical and Health SciencesNeuroblastomaSUZ12Oncogene MYCNCRISPR-Cas SystemCancerPediatricNeuronsN-Myc Proto-Oncogene ProteinTumorEZH2EpigeneticCell DifferentiationGeneral MedicineUp-RegulationGene Expression Regulation NeoplasticOncology5.1 PharmaceuticalsEpigeneticsDevelopment of treatments and therapeutic interventionsHumanResearch ArticlePediatric Research InitiativePediatric CancerImmunologymacromolecular substancesBiologyN-Myc Proto-Oncogene ProteinCell Line03 medical and health sciencesRare DiseasesNeuroblastomaCell Line TumormedicineGeneticsHumansEnhancer of Zeste Homolog 2 ProteinTranscription factorneoplasmsNeoplasticHuman GenomeNeurosciencesGene AmplificationNeuronmedicine.disease030104 developmental biologyGene Expression RegulationCancer researchHistone deacetylaseCRISPR-Cas SystemsThe Journal of clinical investigation
researchProduct

Residential Exposure to Outdoor Air Pollution during Pregnancy and Anthropometric Measures at Birth in a Multicenter Cohort in Spain

2011

Background: A growing body of research suggests that prenatal exposure to air pollution may be harmful to fetal development. We assessed the association between exposure to air pollution during pregnancy and anthropometric measures at birth in four areas within the Spanish Children’s Health and Environment (INMA) mother and child cohort study. Methods: Exposure to ambient nitrogen dioxide (NO2) and benzene was estimated for the residence of each woman (n = 2,337) for each trimester and for the entire pregnancy. Outcomes included birth weight, length, and head circumference. The association between residential outdoor air pollution exposure and birth outcomes was assessed with linear regress…

Questionnaires:Health Care::Environment and Public Health::Public Health::Environmental Pollution::Environmental Exposure::Environmental Monitoring [Medical Subject Headings]Fetus -- CreixementPediatricsHealth Toxicology and MutagenesisEspañaair pollution:Phenomena and Processes::Physiological Phenomena::Body Constitution::Body Weights and Measures::Body Size::Body Weight [Medical Subject Headings]:Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings]Cohort StudiesbenzenebirthRecién NacidoPregnancyResidence CharacteristicsSurveys and Questionnaires:Chemicals and Drugs::Chemical Actions and Uses::Toxic Actions::Environmental Pollutants::Air Pollutants [Medical Subject Headings]:Health Care::Environment and Public Health::Public Health::Environmental Pollution::Environmental Exposure::Maternal Exposure [Medical Subject Headings]Birth WeightBody SizeMedicineProspective StudiesProspective cohort studyTamaño Corporal:Phenomena and Processes::Reproductive and Urinary Physiological Phenomena::Reproductive Physiological Phenomena::Reproductive Physiological Processes::Reproduction::Pregnancy [Medical Subject Headings]:Health Care::Environment and Public Health::Public Health::Epidemiologic Methods::Data Collection::Questionnaires [Medical Subject Headings]Vehicle Emissions:Geographicals::Geographic Locations::Europe::Spain [Medical Subject Headings]Dióxido de NitrógenoPeso al NacerAir PollutantsInhalation ExposureanthropometryAdultoDistribución Espacial de la Población:Chemicals and Drugs::Complex Mixtures::Vehicle Emissions [Medical Subject Headings]Adulto JovenEstudios ProspectivosAire -- Contaminació -- Efectes fisiològics -- EpidemiologiaExposición MaternaHumanos:Health Care::Environment and Public Health::Public Health::Environmental Pollution::Environmental Exposure::Inhalation Exposure [Medical Subject Headings]Maternal ExposureFemeninaInfant Small for Gestational AgeCohort:Named Groups::Persons::Age Groups::Infant::Infant Newborn::Infant Low Birth Weight::Infant Small for Gestational Age [Medical Subject Headings]:Chemicals and Drugs::Inorganic Chemicals::Nitrogen Compounds::Nitrogen Oxides [Medical Subject Headings]Emisiones de VehículosFemalepregnancyEnvironmental MonitoringCohort studyAdultmedicine.medical_specialty:Named Groups::Persons::Age Groups::Adult::Young Adult [Medical Subject Headings]nitrogen dioxideEmbarazoBirth weightMonitoreo del AmbienteExposición por Inhalación:Analytical Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Diagnostic Techniques and Procedures::Physical Examination::Body Constitution::Body Weights and Measures::Body Size [Medical Subject Headings]:Named Groups::Persons::Age Groups::Infant::Infant Newborn [Medical Subject Headings]Young AdultRecién Nacido Pequeño para la Edad Gestacional:Named Groups::Persons::Age Groups::Adult [Medical Subject Headings]HumansPregnancybusiness.industryResearchBencenoInfant NewbornPublic Health Environmental and Occupational Healthbirth weightAnthropometrymedicine.disease:Health Care::Environment and Public Health::Public Health::Epidemiologic Measurements::Demography::Residence Characteristics [Medical Subject Headings]Confidence interval:Chemicals and Drugs::Organic Chemicals::Hydrocarbons::Hydrocarbons Cyclic::Hydrocarbons Aromatic::Benzene [Medical Subject Headings]:Health Care::Environment and Public Health::Public Health::Epidemiologic Methods::Epidemiologic Study Characteristics as Topic::Epidemiologic Studies::Cohort Studies::Prospective Studies [Medical Subject Headings]:Check Tags::Female [Medical Subject Headings]Spain:Analytical Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Epidemiologic Study Characteristics as Topic::Epidemiologic Studies::Cohort Studies [Medical Subject Headings]Contaminantes del AireSmall for gestational ageEstudios de CohortesbusinessDemographyEnvironmental Health Perspectives
researchProduct

Clinical and economic impact of drug eluting beads in transarterial chemoembolization for hepatocellular carcinoma

2015

Summary What is known and objective Drug eluting beads (DEBs) theoretically improve the efficacy and safety of transarterial chemoembolization (TACE) in hepatocellular carcinoma (HCC). Nonetheless, their economic profile has not been assessed. Our retrospective before/after study aimed to compare efficacy, safety and economic profile of two strategies of TACE without (Period 1) or with the possibility of using DEBs (Period 2). Methods All HCC patients treated by TACE in our hospital between March 2006 and May 2013 were included. Economic analyses were performed from the French Public Health Insurance point of view according to the French Diagnosis-Related Group prospective payment system an…

AdultMalesafetymedicine.medical_specialtyCarcinoma HepatocellularCost effectivenesschemoembolisationCost-Benefit AnalysisAntineoplastic AgentsTreatment failureDrug CostsEthiodized OilInternal medicinemedicineOverall survivalHumansPharmacology (medical)Chemoembolization Therapeuticcost-effectivenessAgedRetrospective StudiesPharmacologyAged 80 and overDrug CarriersDrug eluting beadsPublic health insurancebusiness.industryLiver NeoplasmsMiddle Agedmedicine.diseasePrognosisMicrospheres3. Good healthSurgerySurvival RateTreatment OutcomeMedian timeDoxorubicinHepatocellular carcinoma[SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/PharmacologyFemaleProspective payment systembusinessIdarubicin
researchProduct

Efficacy of removing Thermafil and GuttaCore from straight root canal systems using a novel non-surgical root canal re-treatment system : a micro-com…

2021

The present study aims to evaluate the effectiveness of an XP-endo non-surgical root canal re-treatment system in removing both GuttaCore and Thermafil gutta-percha carrier-based root canal filling materials from straight root canal systems using micro-computed tomography (micro-CT) analysis. The study was performed on 20 single-rooted upper teeth, which were randomly allocated into the following study groups: Group A, Thermafil and AH Plus sealer (n = 10)

Study groupsmedicine.medical_specialtynon-surgical root canal re-treatmentEndodontics.Root canalEndodoncia.ThermafilDentistrylcsh:MedicineArticleDientes - Cavidades - Preparación.03 medical and health sciencesTeeth - Roots - Planing.0302 clinical medicinemedicineTeeth - Tomography.030212 general & internal medicinemicro-computed tomographyroot canal filling materialDental therapeutics - Equipment and supplies.Upper teethTerapéutica dental - Aparatos y material.Treatment systembusiness.industryMicro computed tomographylcsh:R030206 dentistryGeneral MedicineRoot Canal Filling MaterialsEndodonticsendodonticsmedicine.anatomical_structureDientes - Tomografía.GuttaCorebusiness
researchProduct

Rectal perforation during defecography: extraluminal barium impaction removed by TEM (Transanal Endoscopic Microsurgery).

2016

Defecography is the standard diagnostic technique for the diagnosis of functional disorders of the posterior pelvic compartment. However it has some limits as radiation exposure, low-contrast resolution, some degrees of embarrassment and discomfort for the patients. Furthermore it often fails to directly visualize the changes that affect the pararectal space. Here we present a never described case of rectal perforation after defecography with barium impaction removed by TEM (Transanal Endoscopic Microsurgery).We present a case of a 50 years old woman with extraluminal barium impaction due to perforation occurred during defecography. Both pelvic MR and endoanal ultrasound confirmed the prese…

Natural Orifice Endoscopic SurgeryMicrosurgeryRectal DiseaseRectumMiddle Agedbarium impaction; defecography; rectal perforation; TEM (transanal endoscopic microsurgery)Magnetic Resonance Imagingbarium impactionRectal Diseasesrectal perforationIntestinal PerforationExtravasation of Diagnostic and Therapeutic MaterialHumansFemaleBarium SulfateTEM (transanal endoscopic microsurgery)UlcerHumanDefecographyExtravasation of Diagnostic and Therapeutic MaterialsUltrasonographyAnnali italiani di chirurgia
researchProduct

The European multicenter cohort study on cyanoacrylate embolization of refluxing great saphenous veins

2014

ObjectiveCyanoacrylate (CA) embolization of refluxing great saphenous veins (GSVs) has been previously described. The outcomes from a multicenter study are still lacking.MethodsA prospective multicenter study was conducted in seven centers in four European countries to abolish GSV reflux by endovenous CA embolization. Neither tumescent anesthesia nor postinterventional compression stockings were used. Varicose tributaries remained untreated until at least 3 months after the index treatment. Clinical examination, quality of life assessment, and duplex ultrasound evaluation were performed at 2 days and after 1, 3, 6, and 12 months.ResultsIn 70 patients, of whom 68 (97.1%) were available for 1…

medicine.medical_specialtymedicine.medical_treatmentPhysical examinationCompression stockingslaw.inventionCohort StudieslawVaricose veinsHumansMedicineSaphenous VeinCyanoacrylatesProspective StudiesEmbolizationProspective cohort studyTumescent anesthesiamedicine.diagnostic_testbusiness.industryRefluxEmbolization TherapeuticSurgeryEuropeTreatment OutcomeVenous InsufficiencyCyanoacrylateAnesthesiaQuality of LifeSurgerymedicine.symptomCardiology and Cardiovascular MedicinebusinessJournal of Vascular Surgery: Venous and Lymphatic Disorders
researchProduct

Research Letter: is neuroticism a risk factor for postpartum depression?

2012

Although the relationship between personality and depressive illness is complex (Shea, 2005), there is empirical evidence that some personality features such as neuroticism, harm avoidance, introversion, dependency, self-criticism or perfectionism are related to depressive illness risk (Gunderson et al. 1999). Moreover, personality traits, especially neuroticism, may explain the increased prevalence of depression among females (Goodwin & Gotlib, 2004). Few studies have explored neuroticism, extraversion and psychoticism as risk factors for depression after an event as stressful as childbirth. Pitt (1968) was the first author to report high scores on neuroticism and low scores on extraversio…

Postpartum depressionNeurotic DisordersDepresión postpartoEvaluación de la personalidad:Named Groups::Persons::Age Groups::Adult::Middle Aged [Medical Subject Headings]medicine.disease_causePersonality Assessment:Analytical Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Probability::Risk::Risk Factors [Medical Subject Headings]:Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings]PregnancyRisk Factors62P ApplicationsBig Five personality traits:Psychiatry and Psychology::Mental Disorders::Neurotic Disorders [Medical Subject Headings]Applied Psychology:Phenomena and Processes::Reproductive and Urinary Physiological Phenomena::Reproductive Physiological Phenomena::Reproductive Physiological Processes::Reproduction::Pregnancy [Medical Subject Headings]education.field_of_studyPerfectionism (psychology)Middle AgedNeuroticismPsychiatry and Mental healthMathematical statistics:Analytical Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Models Statistical::Logistic Models [Medical Subject Headings]:Named Groups::Persons::Age Groups::Adolescent [Medical Subject Headings]Harm avoidanceFemaleEstudios de seguimientoPsychology:Psychiatry and Psychology::Behavioral Disciplines and Activities::Personality Assessment [Medical Subject Headings]Factores de riesgoAdultmedicine.medical_specialtyAdolescent:Named Groups::Persons::Age Groups::Adult::Young Adult [Medical Subject Headings]PopulationEstadísticaDepression PostpartumYoung AdultPsychoticismCorrespondence:Analytical Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Epidemiologic Study Characteristics as Topic::Epidemiologic Studies::Cohort Studies::Longitudinal Studies::Follow-Up Studies [Medical Subject Headings]medicine:Named Groups::Persons::Age Groups::Adult [Medical Subject Headings]Humans:Psychiatry and Psychology::Behavioral Disciplines and Activities::Psychiatric Status Rating Scales [Medical Subject Headings]Escalas de valoración psiquiátricaPsychiatryeducationPsychiatric Status Rating ScalesExtraversion and introversion:Matemàtiques i estadística::Estadística aplicada::Estadística biosanitària [Àrees temàtiques de la UPC]:Psychiatry and Psychology::Mental Disorders::Mood Disorders::Depressive Disorder::Depression Postpartum [Medical Subject Headings]medicine.diseaseLogistic Models:Check Tags::Female [Medical Subject Headings]Trastornos neuróticosFollow-Up Studies
researchProduct

Associations of ofatumumab exposure and treatment outcomes in patients with untreated CLL receiving chemoimmunotherapy

2016

Relationships between patient characteristics, ofatumumab pharmacokinetics, and treatment outcomes were investigated in this phase 2 trial of ofatumumab plus fludarabine and cyclophosphamide (FC) in untreated chronic lymphocytic leukemia. Patients were randomized 1:1 to receive 500 or 1000 mg ofatumumab (Cycle 1; 300 mg) plus FC every 4 weeks for six cycles. Median C(max) and C(trough) values were similar at Cycle 1 regardless of the ultimate clinical outcome. At later doses, these values were higher for patients with complete response (CR) than for other patients. Higher C(max) and C(trough) values at Cycles 3 and 6 were significantly associated with an increased likelihood of CR, whereas …

OncologyMaleCancer ResearchLymphomaDrug ResistanceMedizinKaplan-Meier EstimatePharmacologychemistry.chemical_compound0302 clinical medicineAntineoplastic Agents ImmunologicalRecurrencehemic and lymphatic diseasesAntineoplastic Combined Chemotherapy Protocols80 and overChronicNeoplasm MetastasisLenalidomideCancerAged 80 and overUnivariate analysisLeukemiaRemission InductionAntibodies MonoclonalHematologyphase IIMiddle AgedLymphocyticThalidomideFludarabineClinical trialTreatment OutcomeOncologyTolerability6.1 Pharmaceuticals030220 oncology & carcinogenesisRetreatmentMathematikRituximabFemalePatient SafetyRefractory Chronic Lymphocytic LeukemiaUntreated Chronic Lymphocytic Leukemiamedicine.drugAdultmedicine.medical_specialtyCyclophosphamidelenalidomideClinical Trials and Supportive ActivitiesClinical SciencesImmunologyCmaxAntineoplastic AgentsNeutropeniaOfatumumabAntibodies Monoclonal HumanizedDrug Administration ScheduleArticle03 medical and health sciencesRare DiseasesClinical ResearchChemoimmunotherapyInternal medicinemedicineImmunologic FactorsAnimalsHumansIn patientAdverse effectLenalidomideAgedNeoplasm StagingChromosome Aberrationsbusiness.industryB-CellEvaluation of treatments and therapeutic interventionsmedicine.diseaseHaresLeukemia Lymphocytic Chronic B-CellDiscontinuationClinical trialchemistryDrug Resistance NeoplasmNeoplasmbusinessCLL030215 immunology
researchProduct